MedMira Inc (MIR : TSX-V)
Common Stock
$0.07
CAD
+0.01 (7.69%)
Last updated: 2026-09-03
Get MIR alerts:
MIR
MedMira Inc
WealthAwesomePerformance
1 Day
+7.69%
1 Week
+0.00%
1 Month
+16.67%
YTD
+7.69%
Key Statistics
Market Cap
$49.12M
52W High
$0.11
52W Low
$0.05
P/E Ratio
-
50 Day MA
$0.07
200 Day MA
$0.07
Beta
0.76
Dividend Yield
-
Advertisement
Technical Indicators
Price vs 50-Day SMA
Price vs 200-Day SMA
Recent Price History
| Date | Open | High | Low | Close | Adj Close | Volume |
|---|---|---|---|---|---|---|
| 9/3/2026 | $0.07 | $0.07 | $0.07 | $0.07 | $0.07 | 1,015 |
| 9/2/2026 | $0.07 | $0.07 | $0.07 | $0.07 | $0.07 | 7,400 |
| 8/31/2026 | $0.07 | $0.07 | $0.07 | $0.07 | $0.07 | 119,081 |
| 8/27/2026 | $0.07 | $0.07 | $0.07 | $0.07 | $0.07 | 19,974 |
| 8/25/2026 | $0.07 | $0.07 | $0.07 | $0.07 | $0.07 | 99,000 |
| 8/24/2026 | $0.07 | $0.07 | $0.06 | $0.07 | $0.07 | 61,600 |
| 8/21/2026 | $0.07 | $0.07 | $0.07 | $0.07 | $0.07 | 496,015 |
| 8/20/2026 | $0.06 | $0.06 | $0.06 | $0.06 | $0.06 | 30,000 |
| 8/19/2026 | $0.06 | $0.07 | $0.06 | $0.06 | $0.06 | 280,000 |
| 8/18/2026 | $0.06 | $0.06 | $0.05 | $0.06 | $0.06 | 203,880 |
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on MIR's historical volatility
30-Day Vol
117.0%
Annualized
90-Day Vol
105.9%
Annualized
Trend (90d)
+50.0%
Annualized drift
90d Mean
C$0.08
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$0.07 | C$0.05 – C$0.11 |
| 60 trading days | C$0.08 | C$0.04 – C$0.14 |
| 90 trading days | C$0.08 | C$0.04 – C$0.17 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
About MedMira Inc
MedMira Inc., a biotechnology company, researches, develops, manufactures, and sells rapid diagnostics and technology platforms in North America, Europe, and internationally. The company offers Reveal HIV, a test that detects antibodies to HIV-1 and HIV-2 in whole blood, serum, or plasma; Reveal TP, a rapid syphilis antibody test that detects treponema pallidum antibodies in serum, plasma, or whole blood; Multiplo, a line of multiplex tests for HIV-1/2, Hepatitis B and C, and syphilis; and Miriad triple product for preliminary screening of HIV and hepatitis. It also provides the Miriad RVF toolkit, which facilitates the development and commercialization of rapid diagnostics; and Reveal G4 HIV tests. The company was founded in 1993 and is headquartered in Halifax, Canada. MedMira Inc. is a subsidiary of MedMira Holding AG.
Financials
- Revenue (TTM)
- $370,568
- EBITDA
- $-1.94M
- Profit Margin
- 0.00%
- ROE (TTM)
- 0.00%
- EPS (Diluted)
- 0.00
- Book Value
- -0.04
Classification
- Sector
- Health Care
- Industry
- Biotechnology
- Group
- Pharmaceuticals, Biotechnology & Life Sciences
7 stocks to buy and hold forever
Blue-chip dividend stocks for long-term wealth building.
Get the FREE ReportExplore More
Advertisement
Common Questions About MIR
Market movers
Recent TSX-V movers
Top 1-day gainers — updated from our Canadian movers feed.
MIR.V news timeline
15 articles covering MIR.V, most recent first
LatestWhy MedMira Inc stock is skyrocketing today
August 2026
July 2026
- Why MedMira Inc stock is plummeting today
- Why MedMira Inc stock is skyrocketing today
- Why MedMira Inc stock is plummeting today
- Why MedMira Inc stock surged yesterday
- Why MedMira Inc stock is plummeting today
- Why MedMira Inc stock is plummeting today
- Why MedMira Inc stock is plummeting today
- Why MedMira Inc stock is skyrocketing today